References
- Wentzensen N, Arbyn M. HPV-based cervical cancer screening – facts, fiction, and misperceptions. Prev Med. 2017;98:33–35. DOI:https://doi.org/10.1016/j.ypmed.2016.12.040
- Arrossi S, Paolino M, Laudi R, et al. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy demonstration project in Argentina: a population-based, before-and-after retrospective cohort study. Lancet Glob Health. 2019;7(6):e772–e783. DOI:https://doi.org/10.1016/S2214-109X(19)30048-8
- Tota JE, Bentley J, Blake J, et al. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: acting on evidence to change the current paradigm. Prev Med. 2017;98:5–14. DOI:https://doi.org/10.1016/j.ypmed.2016.11.029
- Arrossi S, Laura T, Paul L. Prevención del cáncer cervicouterino: recomendaciones para el tamizaje, seguimiento y tratamiento de mujeres en el marco de programas de tamizaje basados en el test de VPH: actualización 2015. Ciudad Autónoma de Buenos Aires: Instituto Nacional del Cáncer; 2015.
- Nicolas W, Schiffman Mark P, Timothy AM. Triage of HPV positive women in cervical cancer screening. J Clin Virol. 2016;76(Suppl 1):S49–S55. DOI:https://doi.org/10.1016/j.jcv.2015.11.015
- Arrossi S, Paolino M, Laudi R, et al. Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy demonstration project in Argentina: a population-based, before-and-after retrospective cohort study. Lancet Glob Health. 2019;7:e772–e783. DOI:https://doi.org/10.1016/S2214-109X(19)30048-8
- Torres-Ibarra L, Cuzick J, Lorincz AT, et al. Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus-based screening in Mexico. JAMA Netw Open. 2019;2(11):e1915781. DOI:https://doi.org/10.1001/jamanetworkopen.2019.15781
- Thangarajah F, Einzmann T, Bergauer F, et al. Cervical screening program and the psychological impact of an abnormal pap smear: a self-assessment questionnaire study of 590 patients. Arch Gynecol Obstet. 2016;293(2):391–398. DOI:https://doi.org/10.1007/s00404-015-3821-z
- Jentschke M, Lehmann R, Drews N, et al. Psychological distress in cervical cancer screening: results from a German online survey. Arch Gynecol Obstet. 2020;302(3):699–705. DOI:https://doi.org/10.1007/s00404-020-05661-9
- León-Maldonado L, Allen-Leigh B, Lazcano-Ponce E. Consejería en la detección de VPH como prueba de tamizaje de cáncer cervical: un estudio cualitativo sobre necesidades de mujeres de Michoacán, México. Salud Pública de México. 2014;56(5):519–527. DOI:https://doi.org/10.21149/spm.v56i5.7377
- McBride E, Marlow LAV, Forster AS, et al. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: the psychological impact of primary screening (PIPS) study. Int J Cancer. 2020;146(8):2113–2121. DOI:https://doi.org/10.1002/ijc.32540
- O’Connor M, Costello L, Murphy J, et al. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology. J Fam Plann Reprod Health Care. 2015;41(2):134–141. DOI:https://doi.org/10.1136/jfprhc-2013-100750
- Verhoeven V, Baay MFD, Baay PE, et al. Everything you always wanted to know about HPV (but could not ask your doctor). Patient Educ Couns. 2010;81(1):101–105. DOI:https://doi.org/10.1016/j.pec.2009.12.006
- Marván ML, Y Ehrenzweig, RL Catillo-López. Fatalistic beliefs and cervical cancer screening among Mexican women. Health Care Women Int. 2016;37(1):140–154. DOI:https://doi.org/10.1080/07399332.2014.959169
- Rask M, Swahnberg K, Lindell G, et al. Women’s experiences of abnormal pap smear results – a qualitative study. Sex Reprod Healthc. 2017;12:3–8. DOI:https://doi.org/10.1016/j.srhc.2017.01.002
- Patel H, Moss EL, Sherman SM. HPV primary cervical screening in England: women’s awareness and attitudes. Psychooncology. 2018;27(6):1559–1564. DOI:https://doi.org/10.1002/pon.4694
- Arrossi S, Almonte M, Herrero R, et al. Psycho-social impact of positive human papillomavirus testing in Jujuy, Argentina results from the Psycho-Estampa study. Prev Med Rep. 2020;18:101070. DOI:https://doi.org/10.1016/j.pmedr.2020.101070
- Vamos CA, Calvo AE, Daley EM, et al. Knowledge, behavioral, and sociocultural factors related to human papillomavirus infection and cervical cancer screening among inner-city women in Panama. J Community Health. 2015;40(6):1047–1056. DOI:https://doi.org/10.1007/s10900-015-0030-4
- Hsu Y-Y, Cheng Y-M, Hsu K-F, et al. Knowledge and beliefs about cervical cancer and human papillomavirus among Taiwanese undergraduate women. Oncol Nurs Forum. 2011;38(4):E297–E304. DOI:https://doi.org/10.1188/11.ONF.E297-E304
- Kahn JA, Slap GB, Bernstein DI, et al. Personal meaning of human papillomavirus and pap test results in adolescent and young adult women. Health Psychol. 2007;26(2):192–200. DOI:https://doi.org/10.1037/0278-6133.26.2.192
- Paolino M, Arrossi S. Análisis de los motivos del abandono del proceso de seguimiento y tratamiento por parte de mujeres con lesiones precursoras de cáncer de cuello uterino en la provincia de Jujuy: implicancias para la gestión. Salud Colect. 2012;8:247–261. DOI:https://doi.org/10.1590/S1851-82652012000400003
- Marlow L, Forster AS, McBride E, et al. Information needs among women taking part in primary HPV screening in England: a content analysis. BMJ Open. 2020;10(12):e044630. DOI:https://doi.org/10.1136/bmjopen-2020-044630
- Tiro JA, Betts AC, Kimbel K, et al. Understanding patients’ perspectives and information needs following a positive home human papillomavirus self-sampling kit result. J Womens Health. 2019;28(3):384–392. DOI:https://doi.org/10.1089/jwh.2018.7070
- Liebermann EJ, VanDevanter N, Hammer MJ, et al. Social and cultural barriers to women’s participation in pap smear screening programs in low- and middle-income Latin American and Caribbean countries: an integrative review. J Transcult Nurs. 2018;29(6):591–602. DOI:https://doi.org/10.1177/1043659618755424
- Lai D, Bodson J, Davis FA, et al. Diverse families’ experiences with HPV vaccine information sources: a community-based participatory approach. J Community Health. 2017;42(2):400–412. DOI:https://doi.org/10.1007/s10900-016-0269-4
- Young A, Cotton S, Cruickshank ME. Information needs of young women vaccinated against HPV attending colposcopy: a qualitative study. BMC Women’s Health. 2018;18(1):200. DOI:https://doi.org/10.1186/s12905-018-0691-0
- O’Connor M, Costello L, Murphy J, et al. “I don’t care whether it’s HPV or ABC, I just want to know If I have cancer.” Factors influencing women’s emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study. BJOG: Int J Obstet Gynaecol. 2014;121(11):1421–1429. DOI:https://doi.org/10.1111/1471-0528.12741
- Arrossi S, Thouyaret L, Laudi R, et al. Implementation of HPV-testing for cervical cancer screening in programmatic contexts: the Jujuy demonstration project in Argentina: implementation of HPV testing as primary screening in Argentina. Int J Cancer. 2015;137(7):1709–1718. DOI:https://doi.org/10.1002/ijc.29530
- Daher M, Carré D, Jaramillo A, et al. Experience and meaning in qualitative research: a conceptual review and a methodological device proposal. Forum Qual Sozialforschung/Forum Qual Soc Res. 2017;18(3):Art. 9. DOI:https://doi.org/10.17169/fqs-18.3.2696
- Cuberli M, Arrossi S. Consejería para la prevención del cáncer de cuello de útero. Propuestas para una mejor comunicación con las mujeres durante el tamizaje, seguimiento y tratamiento. Buenos Aires: Instituto Nacional del Cáncer (INC); 2013.
- Strauss A, Corbin J. Bases de la investigación cualitativa. Técnicas y procedimientos para desarrollar la teoría fundamentada. Antioquia: Editorial Universidad de Antioquia; 1990.
- Sharpe PA, Brandt HM, McCree DH. Knowledge and beliefs about abnormal pap test results and HPV among women with high-risk HPV: results from in-depth interviews. Women Health 2006;42(2): 107–133.
- Schoenberg N, Baltisberger J, Bardach S, et al. Perspectives on pap test follow-up care among rural Appalachian women. Women Health. 2010;50(6):580–597. DOI:https://doi.org/10.1080/03630242.2010.516702
- Gálvez A, del Carmen M, Vásquez C, et al. El estigma en mujeres diagnosticadas con VPH, displasia y cáncer cervicouterino en Hermosillo, Sonora. Estud Soc. 2013;21(42):259–278.
- Monsalve-Páez S, Valderrama-Vega D, Castillo-Zamora M, et al. Experiencia de las pacientes frente a citología cérvico-vaginal reportada como ASCUS o LEI de bajo grado en dos instituciones de Bogotá (Colombia), 2014. Rev Colomb Obstet Ginecol. 2015;66(1):14–21. DOI:https://doi.org/10.18597/rcog.3
- World Health Organization. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015. Breaking the chain of transmission. Geneva: World Health Organization; 2015. Available from: http://www.who.int/reproductivehealth/publications/rtis/9789241563475/en/index.html
- McCree Hubbard D, Sharpe PA, Brandt HM, et al. Preferences for sources of information about abnormal pap tests and HPV in women tested for HPV. Prev Med. 2006;43(3):165–170. DOI:https://doi.org/10.1016/j.ypmed.2006.04.001